The Intranasal Administration of 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP): A New Rodent Model to Test Palliative and Neuroprotective Agents for Parkinson's disease

By  

Current Pharmaceutical Design, Vol. 17, Iss. 5, 2011-02 ,pp. : 489-507

Bentham Science Publishers

Access to resources Recommend Favorite

Time-course evaluation of whole blood phagocytosis in mice treated with the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

By Khan Haseeb Ahmad  

Inflammopharmacology, Vol. 12, Iss. 1, 2004-02 ,pp. : 81-88

VSP

Access to resources Recommend Favorite

Axonal Degeneration of Nigra-striatum Dopaminergic Neurons Induced by 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine in Mice

By Li L-H   Qin H-Z   Wang J-L   Wang J   Wang X-L   Gao G-D  

The Journal of International Medical Research, Vol. 37, Iss. 2, 2009-03 ,pp. : 455-463

Field House Publishing

Access to resources Recommend Favorite

Differences in pre- and post-synaptic sensitivity to apomorphine between saline and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated C57BL/6 mice as reflected in climbing activity

By Spooren W.P.J.M.   Vassout A.   Waldmeier P.   Gentsch C.  

European Journal of Pharmacology, Vol. 353, Iss. 1, 1998-07 ,pp. : 1-4

Elsevier

Access to resources Recommend Favorite

Effects of Nicotine on 1-Methyl-4-Phenyl-1,2,5,6-Tetrahydropyridine-Induced Depression of Striatal Dopamine Content and Spontaneous Locomotor Activity in C57 Black Mice

By Gao Z.G.   Cui W.Y.   Zhang H.T.   Liu C.G.  

Pharmacological Research, Vol. 38, Iss. 2, 1998-07 ,pp. : 101-106

Academic Press

Access to resources Recommend Favorite